Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
55.13
-2.24 (-3.90%)
Nov 15, 2024, 4:00 PM EST - Market closed

Revolution Medicines Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Cash & Equivalents
201.26696.15161.41108.5104.2716.66
Upgrade
Short-Term Investments
1,3481,157483.53468.56336.47106.1
Upgrade
Cash & Short-Term Investments
1,5491,853644.94577.05440.74122.76
Upgrade
Cash Growth
90.54%187.31%11.76%30.93%259.03%76.41%
Upgrade
Receivables
-1.254.675.936.398.74
Upgrade
Prepaid Expenses
29.6625.0710.576.796.992.49
Upgrade
Total Current Assets
1,5791,879660.19589.77454.12133.98
Upgrade
Property, Plant & Equipment
99.15100.0173.7471.2436.347.15
Upgrade
Goodwill
14.6114.6114.6114.6114.6114.61
Upgrade
Other Intangible Assets
56.9457.7458.8159.8860.9562.01
Upgrade
Long-Term Deferred Charges
---0.5-2.1
Upgrade
Other Long-Term Assets
13.1610.064.5921.390.68
Upgrade
Total Assets
1,7632,062811.93737.99567.4220.53
Upgrade
Accounts Payable
24.4661.7921.3114.0612.6111.4
Upgrade
Accrued Expenses
76.7370.828.9427.4118.6912.87
Upgrade
Current Portion of Leases
8.47.376.776.213.670.2
Upgrade
Current Unearned Revenue
--4.4612.3612.1117.12
Upgrade
Other Current Liabilities
1.283.90.510.310.11.46
Upgrade
Total Current Liabilities
110.86143.8561.9860.3547.1843.05
Upgrade
Long-Term Leases
78.3180.5857.4360.4228.99-
Upgrade
Long-Term Unearned Revenue
---6.578.4814.73
Upgrade
Long-Term Deferred Tax Liabilities
3.123.127.037.447.447.82
Upgrade
Other Long-Term Liabilities
4.417.970.30.630.632.4
Upgrade
Total Liabilities
196.7235.51126.74135.4292.7367.99
Upgrade
Common Stock
0.020.020.010.010.01-
Upgrade
Additional Paid-In Capital
3,1062,9631,3881,056740.14.74
Upgrade
Retained Earnings
-1,543-1,138-701.34-452.64-265.55-157.39
Upgrade
Comprehensive Income & Other
3.810.54-1.78-0.380.120.07
Upgrade
Total Common Equity
1,5661,826685.19602.57474.68-152.57
Upgrade
Shareholders' Equity
1,5661,826685.19602.57474.68152.54
Upgrade
Total Liabilities & Equity
1,7632,062811.93737.99567.4220.53
Upgrade
Total Debt
86.7187.9464.2166.6332.660.2
Upgrade
Net Cash (Debt)
1,4631,765580.74510.42408.08122.56
Upgrade
Net Cash Growth
94.95%203.93%13.78%25.08%232.97%76.50%
Upgrade
Net Cash Per Share
9.1715.607.207.017.4444.20
Upgrade
Filing Date Shares Outstanding
168.22164.6990.4974.1973.3859
Upgrade
Total Common Shares Outstanding
167.75164.6790.4174.1466.63.29
Upgrade
Working Capital
1,4681,735598.2529.42406.9590.93
Upgrade
Book Value Per Share
9.3411.097.588.137.13-46.35
Upgrade
Tangible Book Value
1,4951,754611.77528.08399.12-229.2
Upgrade
Tangible Book Value Per Share
8.9110.656.777.125.99-69.62
Upgrade
Machinery
32.2928.0921.7414.9811.69.36
Upgrade
Construction In Progress
0.090.51-0.131.98-
Upgrade
Leasehold Improvements
14.111.9511.47.253.393.34
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.